JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2601
CALL
Procter & Gamble
PG
$345B
| $5.8M | ﹤0.01% |
39,000
-6,700
| -15% | -$958K |
2014 Q3
34 quarters
|
|
2602
ArcelorMittal
MT
$49B
| $5.77M | ﹤0.01% |
191,606
+118,777
| +163% | +$3.54M |
2013 Q2
39 quarters
|
|
2603
CALL
Equinix
EQIX
$103B
| $5.77M | ﹤0.01% |
8,000
-25,000
| -76% | -$17.6M |
2022 Q3
2 quarters
|
|
|
GTHX
2604
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $5.76M | ﹤0.01% |
2,149,526
+113,904
| +6% | +$547K |
2017 Q4
21 quarters
|
|
2605
Banc of California
BANC
$2.76B
| $5.75M | ﹤0.01% |
458,527
+32,227
| +8% | +$521K |
2017 Q2
23 quarters
|
|
2606
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.36B
| $5.74M | ﹤0.01% |
127,242
-377
| -0.3% | -$16.7K |
2022 Q1
4 quarters
|
|
2607
Cars.com
CARS
$506M
| $5.74M | ﹤0.01% |
297,621
-32,439
| -10% | -$552K |
2017 Q2
23 quarters
|
|
2608
PUT
Air Products & Chemicals
APD
$62.6B
| $5.71M | ﹤0.01% |
19,900
-20,600
| -51% | -$6.01M |
2022 Q1
4 quarters
|
|
2609
Dycom Industries
DY
$8.77B
| $5.71M | ﹤0.01% |
60,985
-4,444
| -7% | -$413K |
2015 Q1
32 quarters
|
|
2610
Stantec
STN
$7.59B
| $5.7M | ﹤0.01% |
97,605
+57,921
| +146% | +$3.14M |
2020 Q1
12 quarters
|
|
2611
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.29B
| $5.65M | ﹤0.01% |
160,551
+31,324
| +24% | +$1.08M |
2015 Q1
32 quarters
|
|
2612
Talos Energy
TALO
$2.8B
| $5.65M | ﹤0.01% |
380,544
+111,518
| +41% | +$1.92M |
2018 Q2
19 quarters
|
|
2613
PUT
Intuitive Surgical
ISRG
$143B
| $5.59M | ﹤0.01% |
21,900
+1,200
| +6% | +$296K |
2020 Q3
10 quarters
|
|
2614
Logitech
LOGI
$14.7B
| $5.59M | ﹤0.01% |
96,302
-59,340
| -38% | -$3.37M |
2013 Q2
39 quarters
|
|
2615
PUT
Shopify
SHOP
$212B
| $5.59M | ﹤0.01% |
116,600
-132,100
| -53% | -$5.81M |
2021 Q1
8 quarters
|
|
|
HPP
2616
Hudson Pacific Properties
HPP
$627M
| $5.58M | ﹤0.01% |
119,951
+24,917
| +26% | +$1.6M |
2014 Q4
33 quarters
|
|
2617
BridgeBio Pharma
BBIO
$13.1B
| $5.58M | ﹤0.01% |
336,368
-192,757
| -36% | -$2.25M |
2019 Q2
15 quarters
|
|
2618
Li Auto
LI
$10.6B
| $5.57M | ﹤0.01% |
223,242
-19,052
| -8% | -$450K |
2020 Q3
10 quarters
|
|
2619
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$49.9B
| $5.57M | ﹤0.01% |
60,656
+20,664
| +52% | +$1.89M |
2020 Q1
12 quarters
|
|
2620
James River Group Holdings
JRVR
$161M
| $5.57M | ﹤0.01% |
269,608
+6,922
| +3% | +$153K |
2015 Q4
29 quarters
|
|
2621
ARK Genomic Revolution ETF
ARKG
$2.11B
| $5.56M | ﹤0.01% |
184,833
+168,398
| +1,025% | +$5.22M |
2019 Q4
13 quarters
|
|
|
XM
2622
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $5.55M | ﹤0.01% |
311,446
+245,344
| +371% | +$3.75M |
2021 Q1
8 quarters
|
|
|
DFSV
2623
U.S. Small Cap Value Portfolio ETF Class Shares
DFSV
$8.13B
| $5.55M | ﹤0.01% |
222,632
+36,633
| +20% | +$960K |
2022 Q4
1 quarter
|
|
2624
Urban Edge Properties
UE
$2.48B
| $5.54M | ﹤0.01% |
368,054
-70,961
| -16% | -$1.07M |
2015 Q3
30 quarters
|
|
2625
Cemex
CX
$14.3B
| $5.52M | ﹤0.01% |
998,796
+520,445
| +109% | +$2.65M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.